世界の伴侶動物用特殊薬品市場2020-2024

◆英語タイトル:Global Companion Animal Specialty Drugs Market 2020-2024
◆商品コード:IRTNTR44185
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年8月
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、南米、中東アフリカ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、伴侶動物用特殊薬品の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(ワクチン、抗生物質、寄生虫駆除剤、飼料添加物、その他)分析、流通経路別分析、顧客状況、地域状況、企業状況、企業分析などの構成でお届けいたします。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・伴侶動物用特殊薬品の世界市場規模:製品別(ワクチン、抗生物質、寄生虫駆除剤、飼料添加物、その他)
・伴侶動物用特殊薬品の世界市場規模:流通経路別
・顧客状況
・地域状況
・企業状況
・企業分析
【レポートの概要】

Global Companion Animal Specialty Drugs Market 2020-2024

Technavio has been monitoring the companion animal specialty drugs market and it is poised to grow by $ 2.29 bn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our reports on companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in pet humanization, rising awareness about disease prevention and pet insurance, and the rise in aging companion animal population.

The companion animal specialty drugs market analysis includes product segment and geographic landscape.
Technavio’s companion animal specialty drugs market is segmented as below:

By Product
• Vaccines
• Antibiotics
• Parasiticides
• Feed additives
• Other drugs

By Geographic Landscapes
• North America
• Europe
• APAC
• South America
• MEA

This study identifies the enhanced product offerings as one of the prime reasons driving the companion animal specialty drugs market growth during the next few years. Also, an increase in M&A and rising obesity in pets will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our companion animal specialty drugs market covers the following areas:
• Companion animal specialty drugs market sizing
• Companion animal specialty drugs market forecast
• Companion animal specialty drugs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion animal specialty drugs market vendors that include Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Henry Schein Inc., Merck & Co. Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc. Also, the companion animal specialty drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/companion-animal-specialty-drugs-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Vaccines – Market size and forecast 2019-2024
o Antibiotics – Market size and forecast 2019-2024
o Parasiticides – Market size and forecast 2019-2024
o Feed additives – Market size and forecast 2019-2024
o Other drugs – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by Distribution Channel
o Market Segmentation by Distribution Channel
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Bayer AG
o Boehringer Ingelheim International GmbH
o Ceva Sante Animale
o Dechra Pharmaceuticals Plc
o Elanco Animal Health Inc.
o Henry Schein Inc.
o Merck & Co. Inc.
o Vetoquinol SA
o Virbac Group
o Zoetis Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Vaccines – Market size and forecast 2019-2024 ($ million)
• 22: Vaccines – Year-over-year growth 2019-2024 (%)
• 23: Antibiotics – Market size and forecast 2019-2024 ($ million)
• 24: Antibiotics – Year-over-year growth 2019-2024 (%)
• 25: Parasiticides – Market size and forecast 2019-2024 ($ million)
• 26: Parasiticides – Year-over-year growth 2019-2024 (%)
• 27: Feed additives – Market size and forecast 2019-2024 ($ million)
• 28: Feed additives – Year-over-year growth 2019-2024 (%)
• 29: Other drugs – Market size and forecast 2019-2024 ($ million)
• 30: Other drugs – Year-over-year growth 2019-2024 (%)
• 31: Customer landscape
• 32: Impact of drivers and challenges
• 33: Vendor landscape
• 34: Landscape disruption
• 35: Industry risks
• 36: Vendors covered
• 37: Market positioning of vendors
• 38: Bayer AG – Overview
• 39: Bayer AG – Business segments
• 40: Bayer AG – Key offerings
• 41: Bayer AG – Key customers
• 42: Bayer AG – Segment focus
• 43: Boehringer Ingelheim International GmbH – Overview
• 44: Boehringer Ingelheim International GmbH – Business segments
• 45: Boehringer Ingelheim International GmbH – Key offerings
• 46: Boehringer Ingelheim International GmbH – Key customers
• 47: Boehringer Ingelheim International GmbH – Segment focus
• 48: Ceva Sante Animale – Overview
• 49: Ceva Sante Animale – Product and service
• 50: Ceva Sante Animale – Key offerings
• 51: Ceva Sante Animale – Key customers
• 52: Ceva Sante Animale – Segment focus
• 53: Dechra Pharmaceuticals Plc – Overview
• 54: Dechra Pharmaceuticals Plc – Product and service
• 55: Dechra Pharmaceuticals Plc – Key offerings
• 56: Dechra Pharmaceuticals Plc – Key customers
• 57: Dechra Pharmaceuticals Plc – Segment focus
• 58: Elanco Animal Health Inc. – Overview
• 59: Elanco Animal Health Inc. – Product and service
• 60: Elanco Animal Health Inc. – Key offerings
• 61: Elanco Animal Health Inc. – Key customers
• 62: Elanco Animal Health Inc. – Segment focus
• 63: Henry Schein Inc. – Overview
• 64: Henry Schein Inc. – Business segments
• 65: Henry Schein Inc. – Key offerings
• 66: Henry Schein Inc. – Key customers
• 67: Henry Schein Inc. – Segment focus
• 68: Merck & Co. Inc. – Overview
• 69: Merck & Co. Inc. – Business segments
• 70: Merck & Co. Inc. – Key offerings
• 71: Merck & Co. Inc. – Key customers
• 72: Merck & Co. Inc. – Segment focus
• 73: Vetoquinol SA – Overview
• 74: Vetoquinol SA – Business segments
• 75: Vetoquinol SA – Key offerings
• 76: Vetoquinol SA – Key customers
• 77: Vetoquinol SA – Segment focus
• 78: Virbac Group – Overview
• 79: Virbac Group – Business segments
• 80: Virbac Group – Key offerings
• 81: Virbac Group – Key customers
• 82: Virbac Group – Segment focus
• 83: Zoetis Inc. – Overview
• 84: Zoetis Inc. – Business segments
• 85: Zoetis Inc. – Key offerings
• 86: Zoetis Inc. – Key customers
• 87: Zoetis Inc. – Segment focus
• 88: Currency conversion rates for US$
• 89: Research Methodology
• 90: Validation techniques employed for market sizing
• 91: Information sources
• 92: List of abbreviations



【掲載企業】

Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Henry Schein Inc., Merck & Co. Inc., Vetoquinol SA, Virbac Group, Zoetis Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の伴侶動物用特殊薬品市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆